UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001621

2021

Volltextzugriff (PDF)

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

EBioMedicine, 2019-09, Vol.47, p.89-97

2019

Volltextzugriff (PDF)

A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-09, Vol.22 (18), p.4574-4584

2016

Volltextzugriff (PDF)

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Clinical breast cancer, 2019-02, Vol.19 (1), p.47-57

2019

Volltextzugriff (PDF)

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

Investigational new drugs, 2016-02, Vol.34 (1), p.84-95

2016

Volltextzugriff (PDF)

Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study

Breast (Edinburgh), 2015-06, Vol.24 (3), p.182-190

2015

Volltextzugriff (PDF)

Pharmacokinetic drug–drug interaction assessment of peptibody trebananib in combination with chemotherapies

Cancer chemotherapy and pharmacology, 2015-08, Vol.76 (2), p.243-250

2015

Volltextzugriff (PDF)

[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma

Annals of surgical oncology, 2006-02, Vol.13 (2), p.187-197

2006

Volltextzugriff (PDF)

Update on the medical management of pituitary adenomas

Current neurology and neuroscience reports, 2005-05, Vol.5 (3), p.178-185

Pickett, Cheryl A

2005

Volltextzugriff (PDF)

Role of Specific Protein Kinase C Isozymes in Mediating Epidermal Growth Factor, Thyrotropin-Releasing Hormone, and Phorbol Ester Regulation of the Rat Prolactin Promoter in GH4/GH4C1 Pituitary Cells

Molecular endocrinology (Baltimore, Md.), 2002-12, Vol.16 (12), p.2840-2852

2002

Volltextzugriff (PDF)

Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series

Thyroid (New York, N.Y.), 2006-08, Vol.16 (8), p.801-810

2006

Volltextzugriff (PDF)

Altered Expression of Cyclins and Cell Cycle Inhibitors in Papillary Thyroid Cancer: Prognostic Implications

Thyroid (New York, N.Y.), 2005-05, Vol.15 (5), p.461-473

2005

Volltextzugriff (PDF)

Diagnosis and management of pituitary tumors: recent advances

Primary care, 2003-12, Vol.30 (4), p.765-789

Pickett, Cheryl A.

2003

Volltextzugriff (PDF)

Abstract B037: A pharmacodynamic pilot study of DS8201a in patients with HER2 expressing advanced solid tumors

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.B037-B037

2023

Volltextzugriff (PDF)

Abstract B041: A phase 1 study of DS-8201a in combination with olaparib in HER2-expressing malignancies (CTEP #10355): Results of module 1 dose escalation

Molecular cancer therapeutics, 2023-12, Vol.22 (12_Supplement), p.B041-B041

2023

Volltextzugriff (PDF)

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaResearch in context

EBioMedicine, 2019-09, Vol.47, p.89-97

2019

Volltextzugriff (PDF)

Abstract P5-19-14: A phase 1b study of trebananib plus paclitaxel and trastuzumab or capecitabine and lapatinib in patients with HER2+ locally recurrent or metastatic breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-19-14

2015

Volltextzugriff (PDF)

An Unusual Case of Central Hypothyroidism and Thyrotoxicosis Factitia

The Endocrinologist (Baltimore, Md.), 2006-07, Vol.16 (4), p.219-222

Pickett, Cheryl A.

2006

Volltextzugriff (PDF)

Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (18), p.8612-8616

1994

Volltextzugriff (PDF)

Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH(4) neuroendocrine cells

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (18), p.8612

1994

Volltextzugriff (PDF)

Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways

Molecular and Cellular Biology, 1995-12, Vol.15 (12), p.6777-6784

1995

Volltextzugriff (PDF)

Ras Mediates Src but not Epidermal Growth Factor-Receptor Tyrosine Kinase Signaling Pathways in GH4Neuroendocrine Cells

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (18), p.8612-8616

1994

Volltextzugriff (PDF)

10 Phosphorylase Kinase

The Enzymes, 1986, Vol.17, p.395-459

1986

Volltextzugriff (PDF)

Public Support for Policies to Reduce School Shootings: A Moral-Altruistic Model

The journal of research in crime and delinquency, 2021-05, Vol.58 (3), p.269-305

2021

Volltextzugriff (PDF)

Are guns the new dog whistle? Gun control, racial resentment, and vote choice

Criminology (Beverly Hills), 2022-02, Vol.60 (1), p.90-123

2022

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(28)
Female
(21)
Male
(19)
Social Sciences
(17)
Adult
(16)
Biological And Medical Sciences
(13)
Criminology & Penology
(13)
Middle Aged
(13)
Animals
(11)
Aged
(9)
Medical Sciences
(9)
Firearms
(7)
Hypoxia - Physiopathology
(7)
Oncology
(7)
Public Opinion
(7)
Respiratory System
(7)
Covid-19
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study

Pharmacokinetic drug–drug interaction assessment of peptibody trebananib in combination with chemotherapies

[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma

Update on the medical management of pituitary adenomas

Role of Specific Protein Kinase C Isozymes in Mediating Epidermal Growth Factor, Thyrotropin-Releasing Hormone, and Phorbol Ester Regulation of the Rat Prolactin Promoter in GH4/GH4C1 Pituitary Cells

Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series

Altered Expression of Cyclins and Cell Cycle Inhibitors in Papillary Thyroid Cancer: Prognostic Implications

Diagnosis and management of pituitary tumors: recent advances

Abstract B037: A pharmacodynamic pilot study of DS8201a in patients with HER2 expressing advanced solid tumors

Abstract B041: A phase 1 study of DS-8201a in combination with olaparib in HER2-expressing malignancies (CTEP #10355): Results of module 1 dose escalation

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaResearch in context

Abstract P5-19-14: A phase 1b study of trebananib plus paclitaxel and trastuzumab or capecitabine and lapatinib in patients with HER2+ locally recurrent or metastatic breast cancer

An Unusual Case of Central Hypothyroidism and Thyrotoxicosis Factitia

Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells

Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH(4) neuroendocrine cells

Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways

Ras Mediates Src but not Epidermal Growth Factor-Receptor Tyrosine Kinase Signaling Pathways in GH4Neuroendocrine Cells

10 Phosphorylase Kinase

Public Support for Policies to Reduce School Shootings: A Moral-Altruistic Model

Are guns the new dog whistle? Gun control, racial resentment, and vote choice

Suchergebnisse filtern